Summary
Widespread contamination from pharmaceuticals (synthetic or natural chemicals found in prescription medicines, over-the-counter therapeutic drugs & veterinary drugs) are finding their way into the drinking water supply, posing serious threats to public health. Pharmaceutical compounds such as hormones and endocrine disrupters are already responsible of major health problems, but modern wastewater treatment systems are not designed for effective removal of pharmaceuticals.
Pharem Biotech brings to market the first enzyme-carrying filtration system able to remove a large range of organic pollutants (pharmaceuticals and other biological active compounds such as Bisphenol A, PFOS, antibiotics, hormone disruptors, etc.) in wastewater treatment plants, without additional energy requirement. By combining the enzymes with biotechnological techniques and a process for applying the enzymes onto a physical filter, the solution provides a wastewater treatment process step that can be added onto the existing water treatment processes at sewage treatment plants and work without external energy. The solution is based on modified enzymes which are 200 times more effective than native enzymes, resistant to low temperature, resistant to low pH and with high levels of stability and activity.
The solution was successfully demonstrated in an industrial environment (Hammarby Sjöstadsverk in Stockholm, Sweden, a test and demonstration facility for innovative waste water purification run by the Swedish Environmental Institute) where it effectively removed the pharmaceutical and other organic pollutants from urban wastewater at a price that is 10X lower than alternative solutions. Pharem aims to equip 50 WWTPs by 2020, for a turnover of €30M+.
Pharem Biotech brings to market the first enzyme-carrying filtration system able to remove a large range of organic pollutants (pharmaceuticals and other biological active compounds such as Bisphenol A, PFOS, antibiotics, hormone disruptors, etc.) in wastewater treatment plants, without additional energy requirement. By combining the enzymes with biotechnological techniques and a process for applying the enzymes onto a physical filter, the solution provides a wastewater treatment process step that can be added onto the existing water treatment processes at sewage treatment plants and work without external energy. The solution is based on modified enzymes which are 200 times more effective than native enzymes, resistant to low temperature, resistant to low pH and with high levels of stability and activity.
The solution was successfully demonstrated in an industrial environment (Hammarby Sjöstadsverk in Stockholm, Sweden, a test and demonstration facility for innovative waste water purification run by the Swedish Environmental Institute) where it effectively removed the pharmaceutical and other organic pollutants from urban wastewater at a price that is 10X lower than alternative solutions. Pharem aims to equip 50 WWTPs by 2020, for a turnover of €30M+.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/763186 |
| Start date: | 01-12-2016 |
| End date: | 30-04-2017 |
| Total budget - Public funding: | 71 429,00 Euro - 50 000,00 Euro |
Cordis data
Original description
Widespread contamination from pharmaceuticals (synthetic or natural chemicals found in prescription medicines, over-the-counter therapeutic drugs & veterinary drugs) are finding their way into the drinking water supply, posing serious threats to public health. Pharmaceutical compounds such as hormones and endocrine disrupters are already responsible of major health problems, but modern wastewater treatment systems are not designed for effective removal of pharmaceuticals.Pharem Biotech brings to market the first enzyme-carrying filtration system able to remove a large range of organic pollutants (pharmaceuticals and other biological active compounds such as Bisphenol A, PFOS, antibiotics, hormone disruptors, etc.) in wastewater treatment plants, without additional energy requirement. By combining the enzymes with biotechnological techniques and a process for applying the enzymes onto a physical filter, the solution provides a wastewater treatment process step that can be added onto the existing water treatment processes at sewage treatment plants and work without external energy. The solution is based on modified enzymes which are 200 times more effective than native enzymes, resistant to low temperature, resistant to low pH and with high levels of stability and activity.
The solution was successfully demonstrated in an industrial environment (Hammarby Sjöstadsverk in Stockholm, Sweden, a test and demonstration facility for innovative waste water purification run by the Swedish Environmental Institute) where it effectively removed the pharmaceutical and other organic pollutants from urban wastewater at a price that is 10X lower than alternative solutions. Pharem aims to equip 50 WWTPs by 2020, for a turnover of €30M+.
Status
CLOSEDCall topic
SMEInst-11-2016-2017Update Date
27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
H2020-EU.3.5. SOCIETAL CHALLENGES - Climate action, Environment, Resource Efficiency and Raw Materials
